Fig. 1.
a Initial DLBCL (case 3). H&E. b Tumor cells were CD20+ at IHC. c Recurrent DLBCL after Rx treatment showing similar features to the initial DLBCL. H&E. d Recurrent tumor cells were CD20-. Inset Tumor cells were CD79a+. All ×400.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.